![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/30/2938560/10918/en/Nymox-Announces-Filing-of-Annual-Report.html
https://www.globenewswire.com/news-release/2024/07/18/2915548/10918/en/Nymox-Annual-Report.html
https://www.globenewswire.com/news-release/2024/07/16/2913880/10918/en/Nymox-Required-to-Resubmit-Application-to-DKMA.html
https://www.globenewswire.com/news-release/2024/03/27/2853282/10918/en/Nymox-Reports-Victory-in-Bahamas-Litigation-Against-Terminated-Ex-Employees-Court-Awards-Costs-and-Damages.html
https://www.globenewswire.com//news-release/2023/12/27/2801412/10918/en/Nymox-December-27-Message-to-Shareholders.html
https://www.fiercebiotech.com/biotech/nymox-drama-heightens-biotech-sues-ascellahealth-250m-damages
https://www.globenewswire.com//news-release/2023/11/09/2777543/10918/en/Nymox-Pharmaceutical-Corporation-Sues-AscellaHealth-For-250-Million.html
https://www.globenewswire.com//news-release/2023/11/03/2773399/10918/en/NYMOX-REPORTS-Bahamian-Court-Today-Suspends-Order-of-October-3-2023-Rendering-Riley-Lanham-and-Accomplices-Planned-Vote-Unauthorized.html
https://www.globenewswire.com//news-release/2023/11/03/2773267/10918/en/NYMOX-REPORTS-NOTICE-California-Court-Issued-A-Temporary-Restraining-Order-Enjoining-Lanham-Riley-Cutler-And-Their-Nevada-Company-After-Court-Hearing-In-Santa-Ana-California-Novemb.html